VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ACAD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ACADACADIA Pharmaceuticals Inc.
$21.23$3.6B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksACADQuarterly Cash Flow

ACADIA Pharmaceuticals Inc. (ACAD) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

ACADIA Pharmaceuticals Inc. (ACAD) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

ACAD Cash Flow Statement

Quarterly statement

ACAD Cash Flow Statement

ACADIA Pharmaceuticals Inc. (ACAD) cash flow statement — 25-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations11.5M134.76M33.98M-48.73M74.29M63.96M20.32M40.38M63.25M25.01M29.08M85.39M-58.95M8.2M-17.93M-23.85M-727K-13.13M-76.33M-23.12M
Operating CF Margin %3.36%43.76%12.68%-17.16%26.66%24.17%8.32%15.55%25.26%10.34%14.13%36.96%-27.85%4.96%-15.14%-17.48%-0.56%-9.75%-66.1%-17.68%
Operating CF Growth %-84.52%110.71%67.2%-220.68%17.46%155.69%-30.11%-52.71%207.28%205%262.15%457.97%-8009.35%162.48%76.51%-3.17%95.74%48.18%-26.9%15.89%
Net Income53.52M35.14M3.64M273.57M71.78M26.67M18.99M143.74M32.77M33.39M16.55M45.8M-65.18M1.11M-43.02M-41.73M-27.18M-34.01M-113.06M-43.09M
Depreciation & Amortization3.65M3.16M2.99M2.92M2.95M2.94M2.95M5.21M2.57M2.57M5.53M1.64M1.72M1.77M426K489K506K515K516K535K
Stock-Based Compensation17.45M31.64M14.7M013.18M14.34M11.38M10.45M26.16M15.69M14.75M18.02M18.54M15.15M14.71M14.41M18.31M20.51M14.96M12.88M
Deferred Taxes14.4M9.68M-94K-249.88M00000000-50.07M0000000
Other Non-Cash Items27K15.69M-453K12.56M-1.1M-1.54M-2.12M-149.33M-2.75M-1.95M-1.79M-1.78M46.59M-247K-6.61M-3.64M-3.35M597K108K-985K
Working Capital Changes-77.55M39.46M13.2M-87.91M-12.52M21.55M-10.88M30.31M4.49M-24.68M-5.97M21.71M-10.56M-9.59M16.56M6.61M10.98M-738K21.14M7.54M
Change in Receivables-10.37M-17.95M-153K-8.8M-19.75M-5.97M-9.02M5.67M30K-10.31M2.27M-7.82M-10.95M-13.91M-7.17M-6.94M12.75M-5.41M1.86M-3.68M
Change in Inventory1.36M3.9M78K-4.89M1.25M-4.1M-10.45M-4.42M-1.33M-27.15M-16.65M-15.07M-11.22M-3M481K310K640K632K833K217K
Change in Payables-28.22M32.32M1.34M-10.84M1.65M2M1.9M-2.89M-801K550K1.79M5.23M-6.5M1.39M4.68M2.74M-1.85M1.09M3.89M-846K
Cash from Investing-86.15M57.75M66.28M-55.87M-79.35M-43.29M-124.05M122.15M-82.46M-56.19M-14.04M-347K34.11M-194.28M192.52M-17.75M15.44M-55.8M131.34M71.55M
Capital Expenditures-1.24M-10.3M-5.21M-4M-388K98.54M-98.84M-453K-70K000-50K-40M00000-1K
CapEx % of Revenue0.36%3.34%1.94%1.41%0.14%37.25%40.45%0.17%0.03%---0.02%24.21%-----0%
Acquisitions00000000000050K0000000
Investments--------------------
Other Investing00000-98.84M0146.51M0000-50K0000000
Cash from Financing11.87M14.72M4.23M22.67M9.42M15.96M1.84M1.97M268K3.56M1.04M5.43M12.75M5.48M1.47M1.61M287K3.83M2.47M4.37M
Debt Issued (Net)00000000000000000000
Equity Issued (Net)11.87M14.72M4.23M22.67M9.42M15.96M1.84M1.97M268K3.56M1.04M5.43M12.75M5.48M1.47M1.61M287K3.83M2.47M4.37M
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing00000000000000000000
Net Change in Cash-62.62M207.29M104.52M-80.3M4.36M36.64M-101.89M164.44M-18.98M-27.61M16.09M90.46M-12.1M-182.95M176.05M-40M15.01M-65.09M57.48M52.8M
Free Cash Flow10.26M124.46M28.77M-52.74M73.9M162.5M-78.52M39.93M63.18M25.01M29.08M85.39M-59.01M8.2M-17.93M-23.85M-727K-13.13M-76.33M-23.12M
FCF Margin %3%40.41%10.73%-18.57%26.52%61.42%-32.14%15.38%25.23%10.34%14.13%36.96%-27.87%4.96%-15.14%-17.48%-0.56%-9.75%-66.1%-17.68%
FCF Growth %-86.11%-23.41%136.64%-232.08%16.97%549.65%-370.01%-53.24%207.07%205%262.15%457.97%-8016.23%162.48%76.51%-3.17%95.74%48.27%-24.67%21.59%
FCF per Share0.060.720.17-0.310.430.96-0.470.240.380.150.170.51-0.360.05-0.11-0.15-0.00-0.08-0.47-0.14
FCF Conversion (FCF/Net Income)0.21x4.28x9.34x-0.18x1.03x2.40x1.07x0.28x1.93x0.75x1.76x1.86x0.90x7.36x0.42x0.57x0.03x0.39x0.68x0.54x
Interest Paid00000000000000000000
Taxes Paid00000000000000000000